Skip to main content
MESOBLAST LTD logo

MESOBLAST LTD — Investor Relations & Filings

Ticker · MESO ISIN · US5907171046 ASX Manufacturing
Open in API
Filings indexed 2,013 across all filing types
Latest filing 2025-06-12 Regulatory Filings
Country US United States of America
Listing ASX MESO

About MESOBLAST LTD

https://www.mesoblast.com/

Mesoblast is a regenerative medicine company that develops allogeneic (off-the-shelf) cellular medicines for severe and life-threatening inflammatory conditions. The company utilizes its proprietary mesenchymal lineage cell (MSC) technology platform to create treatments for inflammatory ailments, cardiovascular disease, and chronic back pain. The technology sources rare MSCs from the bone marrow of healthy adult donors, which are then expanded using proprietary processes for industrial-scale manufacturing. A key feature of these cells is their ability to be administered without donor-recipient matching or immune suppression. The therapeutic candidates are designed to respond to tissue damage by secreting mediators that promote tissue repair and modulate immune responses. The company's late-stage portfolio includes remestemcel-L for acute graft versus host disease (GVHD) and acute respiratory distress syndrome (ARDS), REVASCOR® for advanced chronic heart failure, and MPC-06-ID for chronic low back pain.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2025-06-12 English
Mesoblast Maintains Momentum with FDA 3 pages 205.4KB
Regulatory Filings Classification · 95% confidence The document is a press release from Mesoblast providing an update on regulatory progress with the FDA regarding accelerated approval pathways and label extensions for their products. It discusses meetings with the FDA, commercial launch updates, and future plans. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is an announcement of regulatory and commercial progress rather than a full report or transcript. It is not a certification, audit, or legal proceeding report. The length is under 10,000 characters and the content is typical of a regulatory or corporate announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2025-06-11 English
Becoming a substantial holder 6 pages 507.7KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001 Section 671B. It details the substantial shareholding of Vanguard Group in Mesoblast Limited, including voting power, relevant interests, registered holders, and a detailed annexure of share transactions (buy and sell) with dates and considerations. This type of filing is a notification of changes in significant share ownership levels, which matches the definition of Major Shareholding Notification (MRQ). The document is lengthy (15,000 characters) and contains detailed shareholding data, not just an announcement or certification. Therefore, it is classified as MRQ with high confidence.
2025-06-05 English
Becoming a substantial holder 36 pages 2.3MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603' and references the Corporations Act 2001 Section 671B, which pertains to the notice of an initial substantial holder. It details the substantial shareholding of JPMorgan Chase & Co. and its affiliates in Mesoblast Ltd, including voting power, relevant interests, associates, and transaction details. The document is a regulatory filing notifying the market and company of a substantial shareholding crossing a threshold. It is not a financial report, earnings release, or management discussion. It is a specific notification of major shareholding as required by law. Therefore, the document fits the category of Major Shareholding Notification (MRQ). The document length and detail support a high confidence in this classification.
2025-06-04 English
Ceasing to be a substantial holder 22 pages 1.6MB
Major Shareholding Notification Classification · 100% confidence The document is a Form 605 under the Corporations Act 2001 Section 671B, titled 'Notice of ceasing to be a substantial holder.' It details changes in relevant interests of a substantial holder (JPMorgan Chase & Co. and affiliates) in the voting securities of Mesoblast Ltd. The form includes specifics about transactions, changes in association, and addresses related to the substantial holder. This type of filing is a regulatory notification about changes in significant share ownership levels, specifically the cessation of substantial holding status. It is not a financial report, earnings release, or management report, but a formal notification of shareholding changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length is substantial and contains detailed transaction data, confirming it is the actual notice, not just an announcement or certification.
2025-06-02 English
Becoming a substantial holder 36 pages 3.3MB
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 603 Corporations Act 2001 Section 671B' and is a 'Notice of initial substantial holder' for Mesoblast Limited. It details the substantial shareholding and voting power of State Street Corporation and its subsidiaries, including specifics on securities held, relevant interests, registered holders, consideration paid, and associates. This type of filing is a notification of a major shareholding or change in significant share ownership levels, as it reports crossing a substantial holding threshold. It is not an annual report, earnings release, or any other financial or management report. It is a regulatory filing specifically related to major shareholding notifications under Australian Corporations Act requirements. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and detail support a high confidence in this classification.
2025-06-02 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.